ROSALINDTM is a smart data platform designed to provide better personalized treatment options to cancer patients based on their genetic profile.
The platform is driven by a dynamic, programmable computer simulation of how cell signaling pathways are altered by specific gene mutations that are associated with specific types of cancers. The resultant mutations determine new cancer cell signaling profiles and identify which pathways have been affected. The underlying patent pending technology produces a comprehensive mathematical model of cell signaling and identifies optimal personalized cancer treatment options.
For more information visit www.ROSALINDonline.com.
